Phase Space AI

Valuation

ExlService Holdings [EXLS]

ExlService Holdings [EXLS] — Valuation

As of 2026-07-30 · spot $34.71 · Company state: A (mature-stable)


1. Base figures

Shares outstanding 152,782,931 (dei cover, 24 Apr 2026)
Market capitalisation $5,303.1m
Cash + short-term investments (30 Jun 2026) $283.824m
Total borrowings (all current) $381.155m
Net debt $97.331m (1.8% of EV)
Enterprise value (lease-exclusive) $5,400.4m
Enterprise value (lease-inclusive, +$101.202m) $5,501.6m
TTM revenue (to 30 Jun 2026) $2,237.314m
TTM operating income (GAAP) $333.318m
TTM operating margin 14.90%
Gross margin 38.0%
TTM free cash flow $275.036m (12.29% margin)
TTM SBC $90.622m (4.05% of revenue)
EV / Sales 2.41x
EV / EBIT 16.20x
EV / FCF 19.6x

TTM FCF margin is positive, so the interim-FCF correction moves conservatively; --fcf-margin 0.1229 was passed explicitly rather than omitted. Q1 free cash flow is negative in both 2025 and 2026 (−$9.7m, −$11.2m) on a recurring annual bonus-payment pattern; the annual sign is unambiguously positive and no forward sign inversion of the GOOGL type applies.


2. Terminal margin — 15.0%

Basis: EXLS's own demonstrated operating margin. Set flat at the FY2025 actual of 15.03% and the window peak, against a TTM of 14.90%.

The five-year record — this is a plateau, not a ramp

FY2021 FY2022 FY2023 FY2024 FY2025 TTM Jun-26
Operating margin 13.89% 13.61% 14.64% 14.34% 15.03% 14.90%

+1.14pp of range over five years while revenue nearly doubled. That is a services business with a stable cost structure, and it is the reason the terminal is set flat rather than expanding.

The initial 15.5% was wrong and steady_state_check said so

This memo first tested a terminal margin of 15.5%, on a mix-shift argument (Data-and-AI-led at 61% of revenue and 46.9% gross margin in Healthcare & Life Sciences). The check returned:

• TERMINAL_ABOVE_EVERY_OBSERVED_YEAR: 15.5% exceeds the window peak of 15.0%. Defensible only with a
  named mechanism — operating leverage on a fixed cost base is a reason; 'it has been rising' is not.

The flag was right and the assumption was revised, not defended. The mechanism failed its own evidence test: Q2 2026 revenue grew 15.6% and GAAP operating margin fell 1.1pp (15.8% → 14.7%), while adjusted margin was flat (+0.1pp). A mix shift that does not reach the operating line in the quarter it is largest is not a margin mechanism. Terminal set to 15.0%.

Opex bridge from 10-K lines (FY2025, % of $2,087.679m revenue)

Line $m % rev
Gross profit 801.076 38.37%
less General & administrative 255.308 12.23%
less Selling & marketing 172.934 8.28%
less Depreciation & amortisation 59.248 2.84%
less other, net (0.164) (0.01%)
= Operating income 313.750 15.03%

Ties to the filed OperatingIncomeLoss of $313,750,000 and OperatingExpenses of $487,326,000. Constraint satisfied: m_EBIT,T 15.0% ≤ m_gross,T 38.4%.

Note the low gross margin. Per the brief's low-margin rule, EV/EBIT becomes an inadmissible instrument at 1–3% operating margins; EXLS runs 15%, comfortably clear of that trigger, and the gross margin of 38.4% is far above the <15% level that forced the MCK/FN switch to EV/gross profit. EV/EBIT is admissible here. Stated explicitly because it was checked.

steady_state_check.py --ticker EXLS --terminal-margin 0.15 --exit-multiple 16.20 --wacc 0.095

MARGIN RAMP
  2020-12-31 margin      11.5%
  latest margin          15.0%
  moved                  +3.5pp   latest is window peak: True
  terminal assumed       15.0%   (-0.0pp vs latest, -0.0pp vs peak)

RETURNS AND THE WARRANTED MULTIPLE
  ROIC measured                                  18.0%
  warranted multiple at steady ROIC              10.1x
  SCALING CONTAMINATION                          1.00x
  terminal reinvestment rate implied by g/ROIC  16.7%
  exit multiple used vs steady-state warranted   1.60x

FINDINGS
  • EXIT_MULTIPLE_UNWARRANTED_AT_STEADY_STATE: 16.2x is 1.6x the 10.1x warranted at a 18%
    steady-state ROIC.

What it flagged after the revision:


3. Implied-path test (primary output)

reverse_dcf.py --spot 34.71 --shares 152.782931 --net-cash -97.331 --revenue 2237.314 --terminal-margin 0.15 --exit-multiple 16.20 --fcf-margin 0.1229 --wacc 0.095

THE MARKET REQUIRES: revenue CAGR of 4.1% Held fixed: terminal margin 15.0%, exit multiple 16.20x EV/EBIT, WACC 9.5%, 5 years.

Required vs demonstrated — and here the bases agree

Demonstrated basis Value Margin (demonstrated − required)
Screen's revenue_cagr_demonstrated +13.9% +9.8pp
Company-guided FY2026 organic growth +13.5% (midpoint of 13–14%) +9.4pp
FY2026 total guided growth (incl. iMerit) +15.0% +10.9pp
Latest quarter YoY +15.6% +11.5pp
Data-and-AI-led (61% of revenue) +30.1% +26.0pp
Digital operations (39% of revenue) −1.5% −5.6pp

Unlike PRGS and PTC, the bases do not disagree in sign. Every consolidated measure — screened, guided, organic, reported, latest-quarter — sits between +13.5% and +15.6% against a required 4.1%. The margin is +9.4pp on the organic basis, and the screen's +8.9pp was, for once, roughly right.

Verdict: PASS. Not "pass with argument" — the required path sits materially below what the business has already demonstrated and below what the company has guided organically, with the acquisition contribution separately quantified at ~1.3 of 15 percentage points.

Sensitivity over the exit multiple

Exit EV/EBIT Percentile of window B Required revenue CAGR vs organic +13.5%
10.1x (ROIC-warranted) below the window low ~11.5% (extrapolated) +2.0pp — still passes
12.0x below window low (15.0x) +9.5% +4.0pp
14.0x below window low +6.7% +6.8pp
16.20x (current, held flat) 18.4th +4.1% +9.4pp
18.9x 20th +1.3% +12.2pp
21.6x 50th −1.0% +14.5pp
28.0x ~85th −5.5% +19.0pp

There is no flip point inside any plausible range. Even at the ROIC-warranted 10.1x — below the lowest multiple EXLS has traded at in the entire post-2024 window (12.1x) — the required ~11.5% still sits below the demonstrated 13.5%. This is the most robust of the three valuation tests in this cluster by a wide margin, and it is robust for the right reason: the required path is low because the demonstrated path is genuinely high, not because the exit multiple is doing the work.

Terminal value exceeds 60% of EV, so the reverse DCF is the primary output per criteria.md.


4. Regime-overlap check — EXLS is the most regime-stable name in the cluster

Daily series from Alpaca split-adjusted closes, 2020-07-27 → 2026-07-29, n = 1,509; current share count and net debt held fixed; TTM revenue lagged 60 days to filing availability. The 5-for-1 split of 2023-08-02 is handled by the split-adjusted feed — confirmed by querying SPLITS explicitly.

Series Window A (2020-07→2023-12) Window B (2024-01→2026-07) Share of B inside A's range
EV/Sales [2.00, 4.66], med 3.46 [1.83, 4.53], med 3.23 97.2%
EV/EBIT [17.5, 35.0], med 27.0 [12.1, 32.5], med 21.6 81.1%

97.2% and 81.1% — both windows describe the same regime. Contrast ZS at 12.7% and PRGS's EV/Sales at 32.2%. EXLS has not re-rated and its earnings have not step-changed; the long series is usable, and the post-2024 window is used for the anchor as the more conservative of the two.

Current Percentile, window B Percentile, full 6y
EV/EBIT 16.20x 18.4th 7.9th
EV/Sales 2.41x 18.0th 11.8th

Window-B EV/EBIT deciles: [15.0, 18.9, 20.1, 20.5, 21.6, 22.9, 24.3, 26.7, 28.4] — a smooth, unimodal distribution with no denominator discontinuity. This is what a valid multiple history looks like, and it is exactly what PTC's is not.


5. Twelve-month target

Forward 12-month revenue and EBIT

FY2026 guidance: $2.390–2.415bn, midpoint $2.4025bn. Carrying forward at ~12% (organic guided 13–14%, moderated for the law of large numbers and the −1.5% Digital operations drag) gives a rolling 12-month revenue one year out of approximately $2,690m. At the 15.0% terminal margin — which is also the current demonstrated margin, so no expansion is assumed — forward EBIT is $403.5m.

Target

Anchor: EV/EBIT 16.20x, the current multiple held flat, at the 18.4th percentile of the regime-valid 2024–26 window. No re-rating assumed.

EV/EBIT anchor Percentile, window B EV less net debt Equity Per share vs $34.71
12.1x (window-B low) 0th $4,882m $97m $4,785m $31.32 −9.8%
15.0x 10th $6,053m $97m $5,955m $38.98 +12.3%
16.20x — BASE, held flat 18.4th $6,537m $97m $6,440m $42.15 +21.4%
18.9x 20th $7,626m $97m $7,529m $49.28 +42.0%
21.6x 50th $8,716m $97m $8,618m $56.41 +62.5%

12-month target: $42 (+21.4%), at 16.20x EV/EBIT = the 18.4th percentile of the 2024–26 own-history window, held flat.

Cross-check on a second instrument

Holding EV/Sales flat at the current 2.41x (18.0th percentile of the same window) on forward revenue of $2,690m: EV $6,483m, less $97m of net debt, over 152.783m shares = $41.80.

The two instruments agree to within 0.8% ($42.15 vs $41.80) because no margin expansion is assumed in either. That agreement is the check that the target is not being manufactured by the multiple.


6. Criteria scoring

Criteria Type Verdict Basis
Quality BINDING PASS COMPOUNDER. ROIC 18.0% vs WACC ~9.5% — the highest measured ROIC of the three names — with an evidenced redeployment mechanism: capex ~16% of NOPAT matching the g/ROIC-implied 16.7%, plus small named tuck-ins (ITI Data, iMerit). Operating margin stable 13.6–15.0% over five years, gross margin 38.0% ± 1pp, positive FCF every year. Accruals: TTM FCF $275m against TTM net income ~$262m — a ~1.05x conversion, healthy.
Valuation BINDING PASS Required 4.1% vs company-guided organic +13.5% = +9.4pp. No flip point exists inside any plausible multiple range, including below the window low. The screened +8.9pp survives verification.
Accounting quality — organic vs acquired MEASURED PASS Organic growth is disclosed and guided separately (+13–14%), with the acquisition contribution quantified in dollars ($28–32m from iMerit, ~1.3 of 15pp). The cleanest disclosure of the three names in this cluster.
Operating leverage MEASURED FAIL — and it is priced accordingly 68% of FY2025 growth came from headcount (+9.2% vs +13.6% revenue); revenue per employee +4.0%, roughly wage inflation. GAAP operating margin fell 1.1pp in Q2 2026 on +15.6% revenue. The terminal margin is set flat because of this, so the failure is absorbed into the model rather than left as an unpriced risk.
Receivables / DSO MEASURED FLAG Same-quarter DSO 61.1d (Q2 2025) → 66.5d (Q2 2026), +5.4 days; receivables +25.7% against revenue +15.6%. Direction is wrong. Magnitude is not disqualifying.
Factoring check MEASURED CLEAN Zero matches for factoring / sale of receivables / securitisation / supply-chain finance in the FY2025 10-K or the Q2 2026 10-Q. The DSO deterioration is therefore real and unmasked — which is a more trustworthy signal than a flattering number would be.
Client concentration MEASURED PASS Top-10 at 34.0% (FY2025), 33.2% (FY2024), 34.0% (FY2023) — high for software, normal for BPO, and stable. No single client above 10%.
AI/analytics revenue share MEASURED DISCLOSED; margin INDETERMINATE Data-and-AI-led $362.558m = 61.0% of Q2 2026 revenue, +30.1%; Digital operations −1.5%. Margin by service type not disclosed. Gross margin by industry segment is disclosed and is the nearest proxy (Healthcare & Life Sciences 46.9% vs ~35% elsewhere).
Retired or redefined metric MEASURED PRESENTATION CHANGE Service-type split (Data-and-AI-led / Digital operations) is a newer presentation than the historical structure; both are currently given, so logged as a change rather than a retirement.
Mention-frequency split MEASURED INDETERMINATE EARNINGS_CALL_TRANSCRIPT not retrieved within the time-box. Missing input is INDETERMINATE, never FAIL.
Steady-state test MEASURED 1 flag EXIT_MULTIPLE_UNWARRANTED_AT_STEADY_STATE at 1.60x — the smallest of the three names. TERMINAL_ABOVE_EVERY_OBSERVED_YEAR fired at a 15.5% terminal and was cleared by revising the assumption to 15.0%, not by arguing with the check.